Your browser doesn't support javascript.
loading
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
Rousseau, Caroline; Goldenberg, David M; Colombié, Mathilde; Sébille, Jean-Charles; Meingan, Philippe; Ferrer, Ludovic; Baumgartner, Pierre; Cerato, Evelyne; Masson, Damien; Campone, Mario; Rauscher, Aurore; Fleury, Vincent; Labbe, Catherine; Chauvet, Alain Faivre; Fresnel, Jean-Sebastien; Toquet, Claire; Barbet, Jacques; Sharkey, Robert M; Campion, Loic; Kraeber-Bodéré, Françoise.
Afiliação
  • Rousseau C; Nuclear Medicine, ICO Cancer Center, Nantes, France c-rousseau@ico.unicancer.fr.
  • Goldenberg DM; CRCINA, University of Nantes, INSERM UMR1232, CNRS-ERL6001, Nantes, France.
  • Colombié M; Immunomedics, Inc., Morris Plains, New Jersey.
  • Sébille JC; IBC Pharmaceuticals, Inc., Morris Plains, New Jersey.
  • Meingan P; Nuclear Medicine, ICO Cancer Center, Nantes, France.
  • Ferrer L; Nuclear Medicine, ICO Cancer Center, Nantes, France.
  • Baumgartner P; Radiology, ICO Cancer Center, Nantes, France.
  • Cerato E; CRCINA, University of Nantes, INSERM UMR1232, CNRS-ERL6001, Nantes, France.
  • Masson D; Physics, ICO Cancer Center, Nantes, France.
  • Campone M; Pharmacy, ICO Cancer Center, Nantes, France.
  • Rauscher A; DRCI, University Hospital, Nantes, France.
  • Fleury V; Biology Department, University Hospital, Nantes, France.
  • Labbe C; Oncology, ICO Cancer Center, Nantes, France.
  • Chauvet AF; Pharmacy, ICO Cancer Center, Nantes, France.
  • Fresnel JS; Nuclear Medicine, ICO Cancer Center, Nantes, France.
  • Toquet C; Radiology, ICO Cancer Center, Nantes, France.
  • Barbet J; Nuclear Medicine, University Hospital, Nantes, France.
  • Sharkey RM; Oncology, ICO Cancer Center, Nantes, France.
  • Campion L; Pathology Department, University Hospital, Nantes, France.
  • Kraeber-Bodéré F; GIP Arronax, Saint-Herblain, France; and.
J Nucl Med ; 61(8): 1205-1211, 2020 08.
Article em En | MEDLINE | ID: mdl-32169921

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Fluordesoxiglucose F18 / Tomografia por Emissão de Pósitrons Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: J Nucl Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Fluordesoxiglucose F18 / Tomografia por Emissão de Pósitrons Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: J Nucl Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França